Effect of pancreatic denervation and atropine on the pancreatic response to secretin.
To study the influence of extrapancreatic nerves and intrapancreatic cholinergic activity on the pancreatic response to secretin, six dogs underwent extrapancreatic denervation and creation of pancreatic fistulae. A second group of six dogs had pancreatic fistulae created without pancreatic denervation. The pancreatic exocrine response to graded doses of secretin (16-500 ng/kg/h) was determined, both alone and during a background infusion of cholecystokinin-octapeptide (CCK8, 50 ng/kg/h). All studies were replicated during administration of atropine (10 micrograms/kg/h). Secretin-induced bicarbonate output was significantly inhibited by atropine in both the innervated and denervated groups. Combined secretin and CCK8 elicited a dose-dependent increase in bicarbonate output and a sustained increase in protein output in both groups, regardless of atropine. In addition, potentiation of secretin-induced bicarbonate output by CCK8 was observed despite both extrinsic pancreatic denervation and administration of atropine. We conclude that endogenous intrapancreatic cholinergic activity influences the pancreatic response to secretin. Potentiation of secretin-induced bicarbonate output by CCK, however, is not dependent on neural mediation.
Kuvshinoff
B W
BW
Department of Surgery, University of Cincinnati Medical Center, Ohio 45267.
Demar
A R
AR
James
L
L
McFadden
D W
DW
Fink
A S
AS
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001639:Bicarbonates / Q000378:metabolism; D003714:Denervation; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D010179:Pancreas / Q000187:drug effects / Q000294:innervation* / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism; D012633:Secretin / Q000008:administration & dosage / Q000494:pharmacology*; D012844:Sincalide / Q000494:pharmacology
D001639:Bicarbonates; D011506:Proteins; D012633:Secretin; D001285:Atropine; D012844:Sincalide